[1]邢士军 王 莉 张丽君.IVIM-MRI对人脑胶质瘤的病理分级及IDH1基因突变的评估价值[J].中国临床神经外科杂志,2020,(12):821-824.[doi:10.13798/j.issn.1009-153X.2020.12.002]
 XING Shi-jun,WANG Li,ZHANG Li-jun..Value of IVIM-MRI in evaluation of pathological grade and IDH1 gene mutation of human glioma[J].,2020,(12):821-824.[doi:10.13798/j.issn.1009-153X.2020.12.002]
点击复制

IVIM-MRI对人脑胶质瘤的病理分级及IDH1基因突变的评估价值()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年12期
页码:
821-824
栏目:
论著
出版日期:
2020-12-25

文章信息/Info

Title:
Value of IVIM-MRI in evaluation of pathological grade and IDH1 gene mutation of human glioma
文章编号:
1009-153X(2020)12-0821-04
作者:
邢士军 王 莉 张丽君
213003 江苏常州,苏州大学附属第三医院神经外科(邢士军、王 莉、王丽君)
Author(s):
XING Shi-jun WANG Li ZHANG Li-jun.
Department of Neurosurgery, The Third Affiliated Hospital of Soochow University (Changzhou First People’s Hospital), Changzhou 213003, China
关键词:
胶质瘤体素不相干运动扩散加权磁共振成像术前评估异柠檬酸盐脱氢酶1
Keywords:
Human glioma Intravoxel incoherent motion magnetic resonance imaging IVIM-MRI Preopertive evaluation
分类号:
R 739.41; R 445.2
DOI:
10.13798/j.issn.1009-153X.2020.12.002
文献标志码:
A
摘要:
目的 探讨体素不相干运动扩散加权(IVIM)-MRI对人脑胶质瘤的病理分级及异柠檬酸盐脱氢酶1(IDH1)突变的评估价值。方法 回顾性分析2016年1月至2019年12月术后病理确诊的100例脑胶质瘤的临床资料。术前应用3.0 T MRI扫描仪检查,获取IVIM-MRI参数,包括灌注比例系数(F)、真实扩散系数(D)、伪扩散系数(D*)与表观扩散系数(ADC)。结果 与高级别胶质瘤相比,低级别胶质瘤ADC值与D值明显增高(P<0.05),而F值与D*值均显著降低(P<0.05)。无论是低级别胶质瘤,还是高级别胶质瘤,IDH1基因突变型病人ADC值显著高于IDH1基因突野生型(P<0.05)。高级别胶质瘤病人中,IDH1基因突变型病人F值、D*值均显著低于IDH1基因野生型(P<0.05)。ROC曲线分析显示,对于鉴别胶质瘤级别,ADC值的最佳临界值为1.091,灵敏度为86.92%,特异度为89.45%;D值的最佳临界值为0.934,灵敏度为78.26%,特异度为94.71%;D*值的最佳临界值为6.161,灵敏度为73.95%,特异度为73.66%;F值的最佳临界值为0.190,灵敏度为56.55%,特异度为100.00%。对于区分IDH1基因型,低级别胶质瘤病人中,ADC值区分IDH1基因突变的最佳临界值为1.181,灵敏度为92.87%,特异度为80.01%;高级别胶质瘤病人中,F值的效能最高,灵敏度为100.00%,特异度为92.87%。结论 IVIM-MRI定量分析可用于胶质瘤术前诊断与分级,并对预测胶质瘤IDH1基因状态具有潜在意义。
Abstract:
Objective To investigate the predictive value of intravoxel incoherent motion (IVIM)-MRI in the evaluation of pathological grade and IDH1 gene mutation of human glioma. Methods A retrospective analysis on the clinical data of 100 patients with glioma diagnosed by postoperative pathological examination from January 2016 to December 2019 was performed. All the patients received IVIM-MRI examination preoperatively using 3.0 T MRI scanner to obtain IVIM-MRI parameters, including perfusion scale coefficient (F), true diffusion coefficient (D), pseudo diffusion coefficient (D*) and apparent diffusion coefficient (ADC). Results The ADC and D values of the low-grade glioma tissues were significantly higher than those of the high-grade glioma tissues (P<0.05), while the F and D* values ??were significantly lower than those of the high-grade glioma tissues (P<0.05) . The ADC values of the low-grade glioma and high-grade glioma tissues with IDH1 gene mutation were significantly higher than those without IDH1 gene mutation (P<0.05). Of high-grade glioma tissues, the F value and D* values of IDH1 gene mutant glioma tissues were significantly lower than those without IDH1 gene mutation (P<0.05). ROC curve analysis showed that, for distinguishing high-grade and low-grade gliomas, the best cut-off value of ADC value was 1.091, with a sensitivity of 86.92% and a specificity of 89.45%; the best cut-off value of the D value was 0.934, with a sensitivity of 78.26% and a specificity of 94.71%; the best cut-off value of the D* value was 6.161, with a sensitivity of 73.95% and a specificity of 73.66%; the best cut-off value of the F value was 0.190, with a sensitivity of 56.55% and a specificity of 100.00%; for distinguishing IDH1 gene mutation in low-grade gliomas, the best cut-off value of the ADC value was 1.181, with a sensitivity of 92.87% and a specificity of 80.01%; for distinguishing IDH1 gene mutation in high-grade gliomas, the F value had the highest efficiency, with a sensitivity of 100.00% and a specificity of 92.87%. Conclusion IVIM-MRI can be used for preoperative diagnosis and grading of gliomas and has potential significance in predicting the IDH1 gene mutation status of gliomas.

参考文献/References:

[1] 周建华,胡 涛,陈 宇,等. lncRNA NEAT1在人脑胶质瘤的表达变化及其与病人预后的关系[J]. 中国临床神经外科杂志,2019,24(3):148-150,161.
[2] 邓小芹,胡心英,邓世强. 术前预康复在脑胶质瘤手术病人中的应用[J]. 中国临床神经外科杂志,2020,25(3):152-154.
[3] 陈云照,张瑞剑,张义松,等. RSF-1在胶质瘤组织中的表达及其与病人预后的关系[J]. 中国临床神经外科杂志,2020,25(9):603-606.
[4] 崔 敬,佟建洲. HOXC10在人脑胶质瘤中的表达及其与病人预后的关系[J]. 中国临床神经外科杂志,2020,25(8):513-516.
[5] Waitkus MS, Diplas BH, Yan H. Isocitrate dehydrogenase mutations in gliomas [J]? Neuro Oncol, 2016, 18(1): 16-26.
[6] 赵宇航,王泽芬,徐成仕,等. 人脑胶质瘤IDH1突变状态与MGMT启动子甲基化、P53和TERT突变相关性[J]. 中国临床神经外科杂志,2018,23(5):339-342.
[7] Zhang J, Xue W, Xu K, et al. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI [J]?Theranostics, 2020, 10(16): 7245-7259.
[8] Yang J, Liao C, Liu Y, et al. MR imaging biomarkers evalu-ating vascular normalization window after anti-vessel treat-ment [J]. Oncotarge, 2017, 9(15): 11964-11976.
[9] Zou T, Yu H, Jiang C, et al. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI [J]? NMR Biomed, 2018, 31(1): 10.
[10] Conklin J, Heyn C, Roux M, et al. A Simplified model for intravoxel incoherent motion perfusion imaging of the brain [J]. AJNR Am J Neuroradiol, 2016, 37(12): 2251-2257.
[11] Shen N, Zhao L, Jiang J, et al. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and micro-perfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumour perfusion [J]. J Magn Reson Imaging, 2016, 44(3): 620-632.
[12] Patella F, Sansone M, Franceschelli G, et al. Quantification of heterogeneity to classify benign parotid tumors: a feasi-bility study on most frequent histotypes [J]. Future Oncol, 2020, 16(12): 763-778.

相似文献/References:

[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
 CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(12):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
 XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(12):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
 LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(12):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
 YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(12):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
 HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(12):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
 DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(12):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
 PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(12):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
 FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(12):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81302197)
更新日期/Last Update: 2020-12-25